Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia patients in Hebei, China, have poor knowledge and negative attitudes but take proactive steps to manage the condition.

People with androgenetic alopecia had milder COVID-19 symptoms during the Omicron wave in China.

Hair loss can indicate various health issues, including serious diseases, hormonal imbalances, and can significantly affect personal life and mental health.

COVID-19 can cause temporary hair loss.

COVID-19 can cause temporary hair loss due to stress and inflammation.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

A 6-year-old girl experienced temporary hair loss after mild COVID-19, which improved naturally in 8 months.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Migrant and minority communities face higher rates of alopecia due to genetic, environmental, and cultural factors, needing better healthcare access and culturally aware treatments.

Recent research on androgenetic alopecia focuses on optimizing treatments, with promising new therapies emerging.

Combining PEMF with PBST is more effective for hair regrowth than PBST alone.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

There have been major advances in diagnosing and treating hair loss over the last 30 years, with new drugs and improved hair transplant techniques.

A girl with hereditary chorea, likely Huntington's disease, had her condition worsened by lupus.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

Metformin may help mild COVID-19 cases, while Oseltamivir, Tamoxifen, and Dexamethasone are suggested for severe cases.

Cancer patients, especially with blood cancers, face severe COVID-19 risks due to weakened immunity.

Healthcare workers with COVID-19 reported more long-term symptoms, and physical activity may help reduce some of these symptoms.

Searches for acne, hair loss, and eczema increased during COVID-19, while searches for other skin issues decreased.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Computer-aided methods can speed up COVID-19 drug discovery and help find new uses for existing drugs.

Post-COVID symptoms are common, affecting over half of the participants.

Long COVID care improved the patient's mobility, breathing, anxiety, and social relationships.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

Nearly half of the patients had Long COVID, leading to health and work issues, especially in high-risk groups.

Long COVID is more common in those with severe initial infections, but not linked to blood group.